Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Orotate phosphoribosyltransferase (OPRT) is an enzyme that plays a crucial role in the de novo biosynthesis of pyrimidine nucleotides. It catalyzes the transfer of a phosphoribosyl group from 5-phospho-α-D-ribose 1-diphosphate (PRPP) to orotate, resulting in the formation of orotidine 5'-monophosphate (OMP) and pyrophosphate. It is involved in cancer therapy response and represents a drug target for antimalarial drug development.
Catalyzes the transfer of a phosphoribosyl group from 5-phospho-α-D-ribose 1-diphosphate (PRPP) to orotate, resulting in the formation of orotidine 5'-monophosphate (OMP) and pyrophosphate. In some instances, it is responsible for converting prodrugs (e.g., 5-FU) into active (or toxic) metabolites.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Orotate Phosphoribosyltransferase (OPRT).